$PFE + $BNTX to scale up mfg of COVID-19 vaccine to millions of doses by end 2020, hundreds of millions in 2021. BNTX to provide multiple mRNA candidates as part of BNT162 program to enter clinic April 2020. BNTX gets $185m UF, $113m equity, up to $563m MS.